Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system.
about
Silaffins in Silica Biomineralization and Biomimetic Silica PrecipitationExtracellular control of intracellular drug release for enhanced safety of anti-cancer chemotherapySelective and ATP-driven transport of ions across supported membranes into nanoporous carriers using gramicidin A and ATP synthase.Increasing the cytotoxicity of doxorubicin in breast cancer MCF-7 cells with multidrug resistance using a mesoporous silica nanoparticle drug delivery systemBiocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals.Stimulus-responsive controlled release system by covalent immobilization of an enzyme into mesoporous silica nanoparticles.Synthesis and Characterization of Chitosan-Coated Near-Infrared (NIR) Layered Double Hydroxide-Indocyanine Green Nanocomposites for Potential Applications in Photodynamic TherapyInvolvement of lysosomal exocytosis in the excretion of mesoporous silica nanoparticles and enhancement of the drug delivery effect by exocytosis inhibition.Delivery of chemically glycosylated cytochrome c immobilized in mesoporous silica nanoparticles induces apoptosis in HeLa cancer cells.Smart Mesoporous Nanomaterials for Antitumor Therapy.Mesoporous silica nanoparticles for intracellular controlled drug delivery.Gated supramolecular chemistry in hybrid mesoporous silica nanoarchitectures: controlled delivery and molecular transport in response to chemical, physical and biological stimuli.Inorganic nanoparticles engineered to attack bacteria.Cathepsin-B induced controlled release from peptide-capped mesoporous silica nanoparticles.Enzyme-responsive intracellular-controlled release using silica mesoporous nanoparticles capped with ε-poly-L-lysine.Introduction of disulfide bridges within silica nanoparticles to control their intra-cellular degradation.Preliminary study of the anticancer applications of mesoporous materials functionalized with the natural product betulinic acid.Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors.Targeted drug delivery into reversibly injured myocardium with silica nanoparticles: surface functionalization, natural biodistribution, and acute toxicityAntibody-capped mesoporous nanoscopic materials: design of a probe for the selective chromo-fluorogenic detection of finasteride.Fatty acid carboxylate- and anionic surfactant-controlled delivery systems that use mesoporous silica supports.An Overview of Nanoparticle Based Delivery for Treatment of Inner Ear Disorders.Modifying mesoporous silica nanoparticles to avoid the metabolic deactivation of 6-mercaptopurine and methotrexate in combinatorial chemotherapy.Enzyme-mediated controlled release systems by anchoring peptide sequences on mesoporous silica supports.Oleochemical-tethered SBA-15-type silicates with tunable nanoscopic order, carboxylic surface, and hydrophobic framework: cellular toxicity, hemolysis, and antibacterial activity.The properties of mesoporous silica nanoparticles functionalized with different PEG-chain length via the disulfide bond linker and drug release in glutathione medium.pH-responsive release of acetal-linked melittin from SBA-15 mesoporous silica.γ-PGA-coated mesoporous silica nanoparticles with covalently attached prodrugs for enhanced cellular uptake and intracellular GSH-responsive release.The intracellular controlled release from bioresponsive mesoporous silica with folate as both targeting and capping agent.Mesoporous Silica Nanoparticles for Drug Delivery and Controlled Release ApplicationsFinely Tuned Temperature-Controlled Cargo Release Using Paraffin-Capped Mesoporous Silica NanoparticlesMesoporous silicananoparticles for the design of smart delivery nanodevicesEnzyme-Mediated Controlled Release Systems by Anchoring Peptide Sequences on Mesoporous Silica SupportsCascaded Photoinduced Drug Delivery to Cells from Multifunctional Core-Shell Mesoporous SilicaRecent Progress on Nanostructures for Drug Delivery Applications
P2860
Q26795747-E15DFC06-14F6-408E-A4ED-4AD0DD9481EDQ28829328-A91482D9-454D-4184-906E-CC576F8D2284Q30268417-1A1B23EC-2363-49EB-B0AA-3F428A842578Q33582877-F4C7F757-A0E9-42EB-A0B3-803D992DBDD7Q34188389-9C60AD75-883D-42CC-A4FA-A891ED6AC894Q35897521-5D418EFE-0DB7-4AD9-B0DE-8EF3E0182328Q36179981-0B3F427D-C722-4521-B1E5-3B6AC82FA81AQ37157022-17B8A3D1-40DE-479F-89F7-DC1ED8EBCA30Q37526755-3D21D99C-B280-4180-BB76-0DF822236D83Q37638621-6D6A2F37-92EC-4913-B8EC-A8F78556B226Q37778327-2B4ED2AC-55CF-4105-8B13-2963C51FD4E8Q38353035-2A5B89BA-75B6-48D1-97D5-F3D348336D54Q38550551-275AF81C-8260-4A20-B719-532730FCE470Q38949120-B36902FA-2CBD-4BEF-AE3F-620FED2A36BBQ39007918-F14B2C9E-FFE2-44BF-B156-925094B34F12Q39178886-22961A68-1882-4D81-93E6-15516BEDA200Q39406009-C774B6ED-B8B0-4C16-A611-9152B4F53BE9Q39702119-AF803F81-CA1C-4381-AB98-8D2F362CA23DQ40380801-6E3475D7-C79A-4536-BD7F-C5796D38938FQ41950764-3E2F2B59-2B9F-4300-84E9-10F6C06469DEQ42964883-40ED5D92-A71A-49F0-9DEA-8DAEDC2D5311Q45887696-A6025448-C6C4-415C-847F-BD8F36A31D64Q46115420-FCE229CC-FE6E-42F2-AEBE-26DFF8F150B2Q46131989-2B55C40A-D7FC-4C44-8839-6F31F9A5AAD0Q50467973-55FA01C6-5624-4D65-8BF6-B1E57E1850DCQ51657611-A8CC529B-D378-476C-96AE-D5F8E910EF76Q52723019-93DCAF82-5A4D-4078-BD69-4C4B01D78311Q52976181-8E44A3DC-80CB-42B3-99A6-C16D30900629Q53763485-613C112B-7B7F-43C0-9200-A174180313E6Q57341237-349502C1-9EA1-4F0D-B336-621EC51BECFDQ57341808-91184C0F-CC5A-4FC4-B47C-13B728FFCC9FQ57364103-04D25231-BB36-4FC6-8AE2-58B4B8B8FB6AQ57401175-272E3849-5EE3-4C3C-BFAC-C33151869908Q57447918-E31B0C23-152D-4D3E-9F32-D8C360631D3FQ59128282-9671770D-B49D-47FB-BDDB-233BEB73A172
P2860
Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Cell-induced intracellular con ...... le-based drug delivery system.
@en
Cell-induced intracellular con ...... le-based drug delivery system.
@nl
type
label
Cell-induced intracellular con ...... le-based drug delivery system.
@en
Cell-induced intracellular con ...... le-based drug delivery system.
@nl
prefLabel
Cell-induced intracellular con ...... le-based drug delivery system.
@en
Cell-induced intracellular con ...... le-based drug delivery system.
@nl
P2093
P356
P1476
Cell-induced intracellular con ...... cle-based drug delivery system
@en
P2093
Barbara Onida
Edoardo Garrone
Juan Vivero-Escoto
Victor S-Y Lin
P304
P356
10.1039/B900559E
P407
P577
2009-05-07T00:00:00Z